Your Health. Your Family. Your Choice.
Administered by: Other Purchased by: ?
Life Threatening? No
Write-up: patient was admitted to the hospital; drug ineffective; SARS-CoV-2 infection; This is a spontaneous report from a contactable Physician. This is a report received from the MHRA. Regulatory authority report number GB-MHRA-ADR 24820376, Safety Report Unique Identifier GB-MHRA-WEBCOVID-202102231206328040. An 85 years old male patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection) on 16Dec2020 at single dose via an unspecified route of administration for COVID-19 immunization. Relevant medical history included Interstitial lung disease, colon cancer on Mar2008, Whipple''s disease. Concomitant medications included alfuzosin, omeprazole and propranolol. On an unspecified date patient had acute diarrhea and was admitted to the hospital. On 11 Jan2021 SARS-CoV-2 infection occurred. Vaccine breakthrough infection (as reported). SARS-CoV-2 test was positive on an unspecified date. On 21Jan2021 the patient died due to Covid 19. Outcome of reported acute diarrhea at time of death was unknown. It was unknown if an autopsy was performed. No follow-up attempts possible; information regarding batch/lot cannot be obtained; No further information expected.; Reported Cause(s) of Death: COVID-19
Copyright © 2022 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166